ALN [American Lorain] 10-Q: FORM 10-Q (Mark One) For the quarterly period

[FORM 10-Q (Mark One) For the quarterly period ended: June 30, 2010 Commission File No. 001-34449 AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Beihuan Road Shandong, China 276600 (86) 539-7318818 Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller reporting company [X] The numbers of] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of American Lorain Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yilun Jin, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of American Lorain Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [of the Sarbanes-Oxley Act of 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2010] [of the Sarbanes-Oxley Act of 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2010] []

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:17:15+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2010

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:19:11+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [AMENDED AND RESTATED CHARTER cphi10qex31063010.htm 2 EX-3.1] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany] [CHINA PHARMAS, 2010 SHARES OPTIONREEMENT China Pharmas, Frank Waung This 2010 Shares Optionreement (thereement) is made of April 28, 2010 between 1. Notice of Shares Option Grant You (the Optionee) have been granted an option to subscribe for, acquire and purchasemmon shares in thempany (themmon Shares), subject to the terms andnditions of the Plan of] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 9, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321063010.htm 11 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 9, 2010 --------------------- (principal financial officer and principal accounting officer) cpho10qex322063010.htm 12 EX-32.2]

By | 2016-02-07T23:25:14+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q: (Original Filing)

[FORM 10-Q (Mark one) x For the quarterly period ended June 30, 2010 Or ¨ For the transition period from ________ to _________ China Automotive Systems, Inc. specified in its charter) Delaware 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) No. 1 Henglong Road, Yu Qiao Development Zone, Shashi District, Jing Zhou City, Hubei Province,] [CERTIFICATION I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu Chief Executive Officer EX-32.1 4 v192765_ex32-1.htm] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer EX-32.2 5 v192765_ex32-2.htm]

By | 2016-03-28T18:10:35+00:00 August 9th, 2010|Categories: CAAS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2010

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [AMENDED AND RESTATED CHARTER cphi10qex31063010.htm 2 EX-3.1] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany] [CHINA PHARMAS, 2010 SHARES OPTIONREEMENT China Pharmas, Frank Waung This 2010 Shares Optionreement (thereement) is made of April 28, 2010 between 1. Notice of Shares Option Grant You (the Optionee) have been granted an option to subscribe for, acquire and purchasemmon shares in thempany (themmon Shares), subject to the terms andnditions of the Plan of] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 9, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321063010.htm 11 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 9, 2010 --------------------- (principal financial officer and principal accounting officer) cpho10qex322063010.htm 12 EX-32.2]

By | 2016-02-07T23:25:46+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CXDC [China XD Plastics Co] 10-Q: (Original Filing)

[CHINA XD PLASTICS COMPANY LIMITED Index PART I— FINANCIAL INFORMATION Page Item 1. Financial Statements 2 Condensed Consolidated Financial Statements (Unaudited) 2 Notes to the Condensed Consolidated Financial Statements (Unaudited) 5 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 37 Item 3. Quantitative and Qualitative Disclosures About Market Risk 44 Item 4T. Controls and Procedures] [入区协议 District Entry Agreement 甲方:哈尔滨经济技术开发区管理委员会 Party A: Harbin Economic and Technological Development Zone Administration 乙方:哈尔滨鑫达高分子材料有限责任公司 Party B: Harbin Xinda Macromolecule Material Co., Ltd. 甲方为支持乙方发展,就企业经营地址迁入哈尔滨经济技术开发区相关事宜及所给予的优惠政策达成如下协议: To support the development of Party B, the business moved to Harbin Economic and Technological Development Zone, address related issues and the preferential policies granted by the agreement reached as follows: 第一条 Article I Committed to] [I, Jie Han, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang, Principal Financial and Accounting Officer]

By | 2016-03-25T18:04:57+00:00 August 9th, 2010|Categories: Chinese Stocks, CXDC, SEC Original|Tags: , , , , , |0 Comments

CXDC [China XD Plastics Co] 10-Q: CHINA XD PLASTICS COMPANY LIMITED Index PART I—

[CHINA XD PLASTICS COMPANY LIMITED Index PART I— FINANCIAL INFORMATION Page Item 1. Financial Statements 2 Condensed Consolidated Financial Statements (Unaudited) 2 Notes to the Condensed Consolidated Financial Statements (Unaudited) 5 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 37 Item 3. Quantitative and Qualitative Disclosures About Market Risk 44 Item 4T. Controls and Procedures] [入区协议 District Entry Agreement 甲方:哈尔滨经济技术开发区管理委员会 Party A: Harbin Economic and Technological Development Zone Administration 乙方:哈尔滨鑫达高分子材料有限责任公司 Party B: Harbin Xinda Macromolecule Material Co., Ltd. 甲方为支持乙方发展,就企业经营地址迁入哈尔滨经济技术开发区相关事宜及所给予的优惠政策达成如下协议: To support the development of Party B, the business moved to Harbin Economic and Technological Development Zone, address related issues and the preferential policies granted by the agreement reached as follows: 第一条 Article I Committed to] [I, Jie Han, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang, Principal Financial and Accounting Officer]

By | 2016-03-25T18:05:50+00:00 August 9th, 2010|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments

SYUT [Synutra International] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended June 30, 2010 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o o o o x o o Large accelerated filer o x] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Donghao Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]

By | 2016-03-18T19:50:50+00:00 August 9th, 2010|Categories: Chinese Stocks, SEC Original, SYUT|Tags: , , , , , |0 Comments

SYUT [Synutra International] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended June 30, 2010 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o o o o x o o Large accelerated filer o x] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Donghao Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]

By | 2016-03-18T19:51:52+00:00 August 9th, 2010|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar